Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
6.92
-0.06 (-0.86%)
At close: May 30, 2025, 4:00 PM
6.90
-0.02 (-0.29%)
After-hours: May 30, 2025, 7:44 PM EDT
Teladoc Health Stock Forecast
Stock Price Forecast
According to 18 professional analysts, the 12-month price target for Teladoc Health stock ranges from a low of $7.00 to a high of $12. The average analyst price target of $9.60 forecasts a 38.73% increase in the stock price over the next year.
Price Target: $9.60 (+38.73%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Teladoc Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 13 | 13 | 11 | 11 | 12 | 12 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 18 | 18 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +1.16% | May 28, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +30.06% | May 27, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +15.61% | May 8, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +73.41% | May 1, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $13 → $10 | Strong Buy | Maintains | $13 → $10 | +44.51% | May 1, 2025 |
Financial Forecast
Revenue This Year
2.57B
from 2.57B
Decreased by -0.06%
Revenue Next Year
2.60B
from 2.57B
Increased by 1.32%
EPS This Year
-1.09
from -5.87
EPS Next Year
-0.80
from -1.09
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.7B | 2.8B | 2.8B | ||
| Avg | 2.6B | 2.6B | 2.7B | ||
| Low | 2.4B | 2.4B | 2.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.7% | 7.1% | 8.7% | ||
| Avg | -0.1% | 1.3% | 2.0% | ||
| Low | -4.7% | -5.6% | -7.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.77 | -0.07 | 0.17 | ||
| Avg | -1.09 | -0.80 | -0.77 | ||
| Low | -1.41 | -1.45 | -1.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.